Tilray Stock Financial Report
Few marijuana stocks have been as disappointing as Tilray Inc (NASDAQ:TLRY).
I’ve written extensively about the malaise that has plagued the company and has sent its share prices careening downward, but it’s worth reiterating: TLRY stock has been an absolute bomb in 2019.
In fact, Tilray stock hasn’t fared well since the immediate aftermath of its initial public offering last summer.
Just take a look at the chart below, comparing Tilray and Cronos Group Inc (NASDAQ:CRON), the only other Nasdaq pure-play marijuana stock.
Chart courtesy of StockCharts.com
It doesn’t take a trained eye to see that Tilray has been getting pummeled; the stock has fallen by more than 30% in 2019.
And, as you can see from the year-long chart below, Tilray stock has been spiraling